Diversified Enterprise EBOS Group is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products, plus animal care brands. This presents cross-selling opportunities across pharma, hospital supplies, and veterinary products to existing and new customers in Australasia.

Strong Growth With revenue approaching NZ$13.5 billion and a 9.9% growth rate in FY26, EBOS demonstrates robust demand across its segments. This indicates opportunity for high-value, contract-based supply arrangements and long-term partnerships with health systems and retailers.

Strategic Expansion Recent acquisitions in pet foods and distribution centre upgrades signal ongoing capacity expansion and product diversification. Sales teams can target integration opportunities, co-branding with newly acquired brands, and distribution efficiency initiatives for larger tier accounts.

Technology Footprint Adopted tech stack includes SAP Concur, NetSuite, SAP/SQL, Microsoft Azure AD, and ERP/CRM tooling. There is potential to offer value-added solutions around procurement optimization, data analytics, and integrated supply chain services to improve cost-to-serve for EBOS and its customers.

Public Markets & Sustainability As a publicly listed group on NZ and Australian exchanges with recognized industry leadership and awards, EBOS is a credible partner for strategic, multi-country deals. Opportunities exist in sustainability-focused packaging, compliance, and ESG-linked supply programs to deepen customer retention and win new contracts.